他汀类药物的临床应用及不良反应研究进展

被引:47
作者
张冰
王莉莉
机构
[1] 军事医学科学院毒物药物研究所
关键词
他汀类; 临床应用; 不良反应; 肝毒性; 肌毒性;
D O I
10.13220/j.cnki.jipr.2013.05.016
中图分类号
R972.6 [];
学科分类号
摘要
他汀类药物是一线降脂药物,也是心血管疾病的预防药物,临床应用和研究范围正不断扩大。他汀类药物临床应用研究主要关注心血管疾病一级预防、充血性心力衰竭的治疗、对糖尿病发病的影响等。近年来,他汀类药物的不良反应,特别是肝毒性和肌毒性也愈发引起人们的关注。肝毒性主要表现为转氨酶升高,严重者引起肝功能衰竭;肌毒性主要表现为肌痛、抽搐等,严重者会引起横纹肌溶解症。临床上主要采用监测血清丙氨酸转氨酶或磷酸肌酸激酶,结合临床表现并及时减量或停药的方法来防止严重不良反应的发生,一些新的治疗方案还在研究中。深入研究他汀类药物不良反应的发生机制,开发有效的辅助治疗方法或复方药物有助于该类药物的安全应用。
引用
收藏
页码:560 / 564+572 +572
页数:6
相关论文
共 41 条
  • [31] Statin myopathy: an update[J] . Lisa Christopher-Stine.Current Opinion in Rheumatology . 2006 (6)
  • [32] Genetic risk factors associated with lipid-lowering drug-induced myopathies
    Vladutiu, Georgirene D.
    Simmons, Zachary
    Isackson, Paul J.
    Tarnopolsky, Mark
    Peltier, Wendy L.
    Barboi, Alexandru C.
    Sripathi, Naganand
    Wortmann, Robert L.
    Phillips, Paul S.
    [J]. MUSCLE & NERVE, 2006, 34 (02) : 153 - 162
  • [33] An Assessment of Statin Safety by Hepatologists[J] . David E. Cohen,Frank A. Anania,Naga Chalasani.The American Journal of Cardiology . 2006 (8)
  • [34] Final Conclusions and Recommendations of the National Lipid Association Statin Safety Assessment Task Force[J] . James M. McKenney,Michael H. Davidson,Terry A. Jacobson,John R. Guyton.The American Journal of Cardiology . 2006 (8)
  • [35] Mild to Moderate Muscular Symptoms with High-Dosage Statin Therapy in Hyperlipidemic Patients —The PRIMO Study[J] . Eric Bruckert,Gilles Hayem,Sylvie Dejager,Caroline Yau,Bernard Bégaud.Cardiovascular Drugs and Therapy . 2006 (6)
  • [36] Improving effect of ethyl eicosapentanoate on statin-induced rhabdomyolysis in Eisai hyperbilirubinemic rats[J] . Hiroyasu Naba,Chihaya Kakinuma,Shuhei Ohnishi,Takuo Ogihara.Biochemical and Biophysical Research Communications . 2005 (1)
  • [37] Statins induce apoptosis in rat and human myotube cultures by inhibiting protein geranylgeranylation but not ubiquinone
    Johnson, TE
    Zhang, XH
    Bleicher, KB
    Dysart, G
    Loughlin, AF
    Schaefer, WH
    Umbenhauer, DR
    [J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 2004, 200 (03) : 237 - 250
  • [38] Safety of Statins: Focus on Clinical Pharmacokinetics and Drug Interactions[J] . Stefano Bellosta,Rodolfo Paoletti,Alberto Corsini.Circulation: Journal of the American Heart Association . 2004 (23 S)
  • [39] Quantifying Effect Of Statins On Low Density Lipoprotein Cholesterol, Ischaemic Heart Disease, And Stroke: Systematic Review And Meta-Analysis[J] . M. R. Law,N. J. Wald,A. R. Rudnicka.BMJ: British Medical Journal . 2003 (7404)
  • [40] Liver fibrosis attributed to lipid lowering medications: two cases[J] . Z.Punthakee,L. J.Scully,M. M.Guindi,T. C.Ooi.Journal of Internal Medicine . 2001 (3)